Average Co-Inventor Count = 4.21
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The Scripps Research Institute (5 from 1,186 patents)
2. Dana-farber-cancer Institute Inc. (3 from 1,206 patents)
3. Beth Israel Deaconess Medical Center, Inc. (3 from 516 patents)
4. Novartis Ag (2 from 3,923 patents)
5. Cornell University (1 from 1,360 patents)
6. Irm LLC (1 from 151 patents)
7. Oregon Health & Science University (504 patents)
8. Ecole Polytechnique Féderale De Lausanne (epfl) (7 patents)
8 patents:
1. 11246873 - Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
2. 10837015 - Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
3. 10660899 - Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
4. 10493080 - Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
5. 10494365 - Small molecule inhibitor of 3-phosphoglycerate dehydrogenase and uses thereof
6. 10138479 - Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
7. 9745631 - Methods for diagnosing and treating oncogenic kras-associated cancer
8. 9592288 - Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate